Messer, Daniel J.
Williams, Morgan D.
Bourne, Matthew N.
Opar, David A.
Timmins, Ryan G.
Shield, Anthony J. http://orcid.org/0000-0002-0393-2466
Article History
Accepted: 9 September 2021
First Online: 28 October 2021
Declarations
:
: No sources of funding were used to assist in the preparation of this article.
: Anthony Shield is listed as a co-inventor on a patent filed for the knee-flexor testing device employed in this study (PCT/AU2012/001041.2012) as well as being a minority shareholder in the company responsible for comercialising the device. David Opar is listed as a co-inventor on a patent filed for a field-testing device of eccentric hamstring strength (PCT/AU2012/001041.2012) and is a minority shareholder in the company responsible for commercialising the device. Data from prototypes of this device are presented in the current manuscript. David Opar is also the Chair of the Vald Performance Research Committee, a role that is unpaid. He has also received funding from Vald Performance for research unrelated to the current manuscript. His brother and brother-in-law are employees of Vald Performance, and his brother is a minority shareholder in Vald Performance Pty Ltd. Matthew Bourne has previously received funding from VALD Performance for research unrelated to the current project. Morgan Williams is a member of the Vald Performance Research Advisory Committee and has previously received travel and subsistence support from VALD Performance for research unrelated to the current project. Daniel Messer and Ryan Timmins have no conflicts of interest to declare.
: DM was involved in the study design, data reanalysis and manuscript write up. AS was involved in the study design and manuscript write up. DO, MB and RT were principal investigators in the three original studies for which AS, DO, RT and MB were involved with recruitment and testing. DO, MB, RT and MW were involved in the study design, and analysis and preparation of this manuscript. All authors had full access to the data in this study and are responsible for the integrity and accuracy of the data analysis.
: The lead author (DM) is the overall guarantor for this manuscript and affirms that the manuscript is an honest, accurate, and transparent account of the study being reported, that no important aspects of the study have been omitted, and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.
: All participants provided written, informed consent for this study, which was approved by the Queensland University of Technology Human Research Ethics Committee and the Australian Catholic University Human Research Ethics Committee. All previous studies were performed in accordance with the standards of ethics outlined in the Declaration of Helsinki.
: Patients or the public were not involved in the design, conduct, reporting or dissemination plans of our research.